Axiom Investment Management LLC Bristol Myers Squibb CO Transaction History

Axiom Investment Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $11 - $6,608	86 New	86 $6,000
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $659,618 - $790,941	-10,729 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$53.63 - $62.52 $495,970 - $578,184	-9,248 Reduced 46.29%	10,729 $668,000
Q3 2021 Oct 18, 2021	SELL	$59.17 - $69.31 $1.54 Million - $1.8 Million	-26,008 Reduced 56.56%	19,977 $1.18 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $2.7 Million - $3.04 Million	45,551 Added 10495.62%	45,985 $2.9 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $25,059 - $28,396	434 New	434 $214,000
Q4 2019 Mar 16, 2021	SELL	$49.21 - $64.19 $1.83 Million - $2.39 Million	-37,197 Closed	0 $0
Q3 2019 Mar 16, 2021	SELL	$42.77 - $50.71 $4.4 Million - $5.21 Million	-102,803 Reduced 73.43%	37,197 $1.89 Million
Q2 2019 Mar 16, 2021	SELL	$44.62 - $49.34 $23,113 - $25,558	-518 Reduced 0.37%	140,000 $6.36 Million
Q1 2019 Mar 16, 2021	BUY	$45.12 - $53.8 $90,285 - $107,653	2,001 Added 1.44%	140,518 $6.73 Million
Q4 2018 Oct 23, 2020	BUY	$48.76 - $63.23 $6.75 Million - $8.76 Million	138,517 New	138,517 $7.2 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Axiom Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Axiom Investment Management LLC with notifications on news.